Making it easier to fly more than one airline to your destination
Stories you may have missed from the world of business.
Stay updated with breaking news from Eisai Co. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Stories you may have missed from the world of business.
A research team at the University of Tokyo says it has detected accumulations of proteins believed to cause Alzheimer's in blood samples taken from Japanese people with mild or no symptoms, potentially allowing easier and earlier detection of the disease.
Adlai Nortye Ltd. announced that the first patient was dosed in the Phase II clinical trial known as ARTEMIS . This clinical study evaluates palupiprant , a small molecule prostaglandin E receptor 4 ...
Marketresearch.biz reports that the Epilepsy Treatment Market size is expected to be worth around USD 13.4 Bn by 2032 from USD 6.5 Bn in 2022, growing at a CAGR of 7.7% during the forecast period from 2023 to 2032.Overview of the Epilepsy Treatment MarketThe Epilepsy Treatment Market focuses on providing therapeutic...
Eisai London, April 2nd, 2024 - CNX Therapeutics Limited (“CNX Therapeutics”), a speciality pharmaceutical company with a portfolio of medicines for the treatment of central nervous system (CNS) disorders and hospital emergencies in over 40 countries worldwide, is pleased to announce that it has suc...